Ever since the first successful donor cord blood transplants were performed in the mid 1990's, the collection and storage of cord blood has been a viable medical process, allowing for the potential cures of many blood and immune-system related genetic diseases, cancers, and disorders. In 2005, the United States passed legislation to increase usage and research into cord blood stem cells, and designated a quarter of a billion dollars for stem cell therapy, umbilical cord blood and bone marrow treatments.

As a result of that decision, cord blood collection by public, non-profit, and private sectors has increased dramatically, and facilities in the public sector are hard-pressed to keep up with the need and demand for cord blood storage. Private cord blood banks and cord blood collection and storage services are growing, and while some disagree with the way that stem cell research is rocketing to the forefront of science, and the ethical validity of storing cord blood is being questioned, cord blood services are thriving.

There is great promise in stem cell research, and while not every genetic disease and disorder is being cured, many agree that cord blood storage provides a better means of curing some conditions than not storing it at all.